U.S. In Vitro Diagnostics (IVD) Market - Global Major Manufacturers Production and Sales Market Comparison
The U.S. IVD product & services market is broadly segmented into reagents, instruments, services, and data management system/software. The instruments market is further segmented into fully automated instruments, semi-automated instruments, and other inst
(EMAILWIRE.COM, December 07, 2018 ) U.S. IVD market is segmented into hospital laboratories, clinical/independent laboratories, and others. In 2017, the hospital laboratories segment accounted for largest share of U.S. IVD market in U.S. The high inpatient flow & ancillary outpatient flow in hospitals, growing prevalence of chronic & infectious diseases, & increasing number of accredited laboratories are key factors driving market growth in this end-user segment.
Get Free Market Updates Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=512828 .
In vitro diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for the diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases, thus helping physicians to diagnose and treat diseases promptly and effectively. The most important trend witnessed recently in the U.S. IVD industry is the trend of self-testing as opposed to patients visiting hospitals.
This is a key factor driving the growth of point-of-care testing, as patients prefer self-testing to avoid hospital visits. IVD tests have a significant role in the prevention, monitoring, diagnosis, and treatment of diseases. Common IVD tests include blood tests for glucose, tests for detection of electrolytes (calcium, sodium, and potassium), liver enzymes, and drug tests.
Get Upto 30% Discount Now at http://www.reportsnreports.com/contacts/discount.aspx?name=512828 .
The U.S. IVD market is projected to reach USD 25.99 billion by 2020 at a CAGR of 4.7% from 2015 to 2020. The rising incidence of chronic and infectious diseases, rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing demand for automated instruments, and automation in laboratories are key factors driving the IVD market in the U.S. In this report, the market is segmented by product & service, technology, application, end user, and region.
Drivers
Rapid growth in geriatric population and increasing incidence of chronic diseases
Increasing adoption of point-of-care (POC) testing
Growing awareness on personalized medicine
Implementation of the Affordable Care Act (ACA)
Increasing adoption of automated instruments and automation in laboratories
Restraints
Unfavorable reimbursement scenario
Rising healthcare cost and low budgets
The major players in the U.S. IVD market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Johnson & Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), QIAGEN N.V. (Netherlands), Alere Inc. (U.S.), Ortho-Clinical Diagnostics Inc. (U.S.), and bioMιrieux (France).
More Information on U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020 research report can be requested at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=512828 .
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on product portfolios offered by top players in the U.S. IVD market. The report analyzes the U.S. IVD market by product, technology, end user, and application across all regions
Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the U.S. IVD market
Market Development: Comprehensive information on the lucrative emerging markets by product, technology, end user, application, and region
Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the U.S. IVD market
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of leading players in the U.S. IVD market.
Get Free Market Updates Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=512828 .
In vitro diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for the diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases, thus helping physicians to diagnose and treat diseases promptly and effectively. The most important trend witnessed recently in the U.S. IVD industry is the trend of self-testing as opposed to patients visiting hospitals.
This is a key factor driving the growth of point-of-care testing, as patients prefer self-testing to avoid hospital visits. IVD tests have a significant role in the prevention, monitoring, diagnosis, and treatment of diseases. Common IVD tests include blood tests for glucose, tests for detection of electrolytes (calcium, sodium, and potassium), liver enzymes, and drug tests.
Get Upto 30% Discount Now at http://www.reportsnreports.com/contacts/discount.aspx?name=512828 .
The U.S. IVD market is projected to reach USD 25.99 billion by 2020 at a CAGR of 4.7% from 2015 to 2020. The rising incidence of chronic and infectious diseases, rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing demand for automated instruments, and automation in laboratories are key factors driving the IVD market in the U.S. In this report, the market is segmented by product & service, technology, application, end user, and region.
Drivers
Rapid growth in geriatric population and increasing incidence of chronic diseases
Increasing adoption of point-of-care (POC) testing
Growing awareness on personalized medicine
Implementation of the Affordable Care Act (ACA)
Increasing adoption of automated instruments and automation in laboratories
Restraints
Unfavorable reimbursement scenario
Rising healthcare cost and low budgets
The major players in the U.S. IVD market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Johnson & Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), QIAGEN N.V. (Netherlands), Alere Inc. (U.S.), Ortho-Clinical Diagnostics Inc. (U.S.), and bioMιrieux (France).
More Information on U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020 research report can be requested at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=512828 .
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on product portfolios offered by top players in the U.S. IVD market. The report analyzes the U.S. IVD market by product, technology, end user, and application across all regions
Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the U.S. IVD market
Market Development: Comprehensive information on the lucrative emerging markets by product, technology, end user, application, and region
Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the U.S. IVD market
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of leading players in the U.S. IVD market.
Contact Information:
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results